Theralase Technologies, Inc. (TLT.V)
0.265
0.00 (0.00%)
CAD |
TSXV |
Mar 04, 12:24
Theralase Technologies Market Cap : 68.12M for March 4, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cannara Biotech, Inc. (DELISTED) | 179.11M |
| Arch Biopartners, Inc. | 53.55M |
| Biocure Technology, Inc. | 0.7072M |
| Resverlogix Corp. | 37.35M |
| Microbix Biosystems, Inc. | 33.25M |
Market Cap Related Metrics
| PS Ratio | 65.84 |
| Price to Book Value | 62.35 |
| Price | 0.265 |
| Earnings Yield | -6.57% |